Manpreet Singh
Child & Adolescent Psychiatry · Sacramento, CANPI 1093888208
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $84,129 of the $103,670 with a category attached, or 81.2%. 15 manufacturers reported payments, led by AbbVie at 36.3% of the total. 2025 is the largest year on record at $62,252, more than ten times the $63 reported in 2019. Among child & adolescent psychiatry clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 120 payments — averaging $863.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$38K
- Janssen Global Services, LLC$24K
- Sunovion Pharmaceuticals Inc.$11K
- Boehringer Ingelheim$8K
- E.r. Squibb & Sons, L.L.C.$8K
- Janssen Research & Development, LLC$8K
- plus $7K from 9 others
Across 33 payments — averaging $4328.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$79K
- AbbVie$64K
What the payments were for
- Consulting fees$84,12981%
- Travel & lodging$16,72916%
- Food & beverage$2,8133%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 41 | $37,683 |
| Janssen Global Services, LLC | 25 | $24,155 |
| Sunovion Pharmaceuticals Inc. | 9 | $10,662 |
| Boehringer Ingelheim | 7 | $8,395 |
| E.r. Squibb & Sons, L.L.C. | 9 | $8,014 |
| Janssen Research & Development, LLC | 7 | $7,824 |
| Alkermes, Inc. | 7 | $3,489 |
| Axsome Therapeutics, Inc. | 2 | $2,559 |
| Abbott | 2 | $332 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $195 |
| Supernus Pharmaceuticals, Inc. | 3 | $168 |
| Tris Pharma Inc | 2 | $58 |
| Sage Therapeutics, LLC | 1 | $57 |
| Neurocrine Biosciences, Inc. | 1 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$103,670 in reported general payments places this provider in the 95th percentile of 434 child & adolescent psychiatry providers in California.
See all child & adolescent psychiatry providers in California →
Other child & adolescent psychiatry in Sacramento
- Joseph SisonSacramento$2K
- Kevin CoxOjai$2.9M
- Sukhjit BrarFresno$283K
- Ihab SolimanCorona del Mar$93K
- Syed NaqviLos Angeles$69K
- Ellen HeynemanSan Diego$62K
- Mark McDonaldLos Angeles$31K
- James HartmanDanville$21K
- Mohsin KhaliqueSan Ramon$20K
- Mansoor ZuberiWalnut Creek$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.